| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0003 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.002 |